Hengruiyuan
Hengruiyuan is a biopharmaceutical company that develops medications based on immune cell treatment technologies for solid tumors.
Hengruiyuan is a company in biopharma, biotechnology, medical, product research based in Asia-Pacific (APAC), founded in 2015.
Its activity falls under biopharma, biotechnology, medical, product research; the profile below is assembled from public directory data.
Its base of operations is Asia-Pacific (APAC).
Directory data places it at the Series_C stage.
The company reports a headcount in the c_00501_01000 range.
It has disclosed roughly $300M in funding.
| Sector | Biopharma, Biotechnology, Medical, Product Research |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2015 |
| Employees | c_00501_01000 |
| Stage | series_c |
| Total funding | $300,000,000 |
Website: www.shhryz.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account